Page last updated: 2024-08-25

adriamycinol and Neutropenia

adriamycinol has been researched along with Neutropenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gustafson, DL; Ramirez, D; Weishaar, K; Wittenburg, LA1
Adkins, D; Butrynski, JE; Chawla, SP; Cranmer, LD; Ganjoo, KN; Kroll, S; Langmuir, VK; Lorente, G; Okuno, SH; Rushing, D1

Trials

1 trial(s) available for adriamycinol and Neutropenia

ArticleYear
A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.
    Oncology, 2011, Volume: 80, Issue:1-2

    Topics: Abscess; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cellulitis; Disease-Free Survival; Doxorubicin; Drug Eruptions; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphopenia; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neutropenia; Nitroimidazoles; Phosphoramide Mustards; Sarcoma; Stomatitis; Treatment Outcome; Young Adult

2011

Other Studies

1 other study(ies) available for adriamycinol and Neutropenia

ArticleYear
Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancers.
    Veterinary and comparative oncology, 2019, Volume: 17, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Area Under Curve; Chromatography, High Pressure Liquid; Colorado; Dog Diseases; Dogs; Doxorubicin; Female; Linear Models; Male; Neoplasms; Neutropenia; Schools, Veterinary

2019